The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
111501593 11150159 3 F 20150428 20160810 20150529 20160812 EXP US-AMGEN-USACT2015045170 AMGEN 53.00 YR A M Y 97.80000 KG 20160812 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
111501593 11150159 1 PS carfilzomib CARFILZOMIB 1 Intravenous (not otherwise specified) 20 MG/M2, PER CHEMO REGIM N 202714 20 MG/M**2 INTRAVENOUS INFUSION
111501593 11150159 2 SS IBRUTINIB IBRUTINIB 1 Oral 560 MG, PER CHEMO REGIM 0 560 MG CAPSULE
111501593 11150159 3 SS DEXAMETHASONE. DEXAMETHASONE 1 Oral 20 MG, PER CHEMO REGIM 0 20 MG
111501593 11150159 4 C MORPHINE MORPHINE 1 UNK 0
111501593 11150159 5 C OXYCONTIN OXYCODONE HYDROCHLORIDE 1 UNK 0
111501593 11150159 6 C ACYCLOVIR. ACYCLOVIR 1 UNK 0
111501593 11150159 7 C ALLOPURINOL. ALLOPURINOL 1 UNK 0
111501593 11150159 8 C SULFAMETHOXAZOLE SULFAMETHOXAZOLE 1 UNK 0
111501593 11150159 9 C COMBIVENT ALBUTEROL SULFATEIPRATROPIUM BROMIDE 1 UNK 0
111501593 11150159 10 C GABAPENTIN. GABAPENTIN 1 UNK 0
111501593 11150159 11 C PANTOPRAZOLE PANTOPRAZOLE SODIUM 1 UNK 0
111501593 11150159 12 C NORCO ACETAMINOPHENHYDROCODONE BITARTRATE 1 UNK 0
111501593 11150159 13 C KEFLEX CEPHALEXIN 1 UNK 0
111501593 11150159 14 C TYLENOL ACETAMINOPHEN 1 UNK 0
111501593 11150159 15 C ZOMETA ZOLEDRONIC ACID 1 UNK 0
111501593 11150159 16 C BACTRIM DS SULFAMETHOXAZOLETRIMETHOPRIM 1 UNK 0
111501593 11150159 17 C VERSED MIDAZOLAM HYDROCHLORIDE 1 UNK 0

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
111501593 11150159 1 Plasma cell myeloma
111501593 11150159 2 Plasma cell myeloma
111501593 11150159 3 Plasma cell myeloma

Outcome of event

Event ID CASEID OUTC COD
111501593 11150159 DE
111501593 11150159 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
111501593 11150159 Acute kidney injury
111501593 11150159 Bronchopulmonary aspergillosis
111501593 11150159 Respiratory failure

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
111501593 11150159 1 20150319 20150429 0
111501593 11150159 2 20150326 20150429 0
111501593 11150159 3 20150319 20150429 0
111501593 11150159 4 20140619 0
111501593 11150159 5 20140627 0
111501593 11150159 6 20150223 0
111501593 11150159 7 20150306 0
111501593 11150159 9 20150419 0
111501593 11150159 10 20150223 0
111501593 11150159 11 20150220 0
111501593 11150159 13 20150326 0
111501593 11150159 14 20150402 0
111501593 11150159 15 201102 0
111501593 11150159 16 20150302 0